| Pratiksha Bothara, | |
|
100 Becks Woods Dr, Bear, DE 19701-3835 | |
| (302) 392-3400 | |
| (302) 392-3401 |
| Full Name | Pratiksha Bothara |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 100 Becks Woods Dr, Bear, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497235402 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT016477 (Ohio) | Secondary |
| 225100000X | Physical Therapist | (Delaware) | Primary |
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061101000380 |
News Archive
A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.
The New York Times: A legal case now pending asks a question increasingly faced by the medical world - "who should be held accountable when a company sells a flawed product that can injure or kill patients? Is it the company or the people who run it?"
Viragen and its majority-owned subsidiary, Viragen International have announced that a licensing agreement has been completed with Swedish Orphan International AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha interferon) for the European Union (excluding previously licensed member states).
Cell Therapeutics, Inc., a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri in the European Union with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012.
› Verified 7 days ago
| Provider Name | The Back Clinic, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1275513368 PECOS PAC ID: 9739274846 Enrollment ID: O20071004000652 |
News Archive
A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.
The New York Times: A legal case now pending asks a question increasingly faced by the medical world - "who should be held accountable when a company sells a flawed product that can injure or kill patients? Is it the company or the people who run it?"
Viragen and its majority-owned subsidiary, Viragen International have announced that a licensing agreement has been completed with Swedish Orphan International AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha interferon) for the European Union (excluding previously licensed member states).
Cell Therapeutics, Inc., a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri in the European Union with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pratiksha Bothara, 790 Remington Blvd, Bolingbrook, IL 60440-4909 Ph: (866) 370-8206 | Pratiksha Bothara, 100 Becks Woods Dr, Bear, DE 19701-3835 Ph: (302) 392-3400 |
News Archive
A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.
The New York Times: A legal case now pending asks a question increasingly faced by the medical world - "who should be held accountable when a company sells a flawed product that can injure or kill patients? Is it the company or the people who run it?"
Viragen and its majority-owned subsidiary, Viragen International have announced that a licensing agreement has been completed with Swedish Orphan International AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha interferon) for the European Union (excluding previously licensed member states).
Cell Therapeutics, Inc., a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri in the European Union with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012.
› Verified 7 days ago
Meredith Tenerow Walker, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1015 E Songsmith Dr, Bear, DE 19701 Phone: 302-836-5670 | |
Melissa Hemphill, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1015 E Songsmith Dr, Bear, DE 19701 Phone: 302-836-5670 Fax: 302-836-5226 | |
Dr. Eduardo Diaz, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1651 Pulaski Hwy, Bear, DE 19701 Phone: 302-834-1550 | |
Mr. Christopher Aaron Goetz, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1651-53 Pulaski Highway, Bear, DE 19701 Phone: 302-834-1550 Fax: 302-834-1549 | |
Sarah Catherine Flynn, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 925 Bear Corbitt Rd, Bear, DE 19701 Phone: 302-454-2400 | |
Mary Nather, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1651-53 Pulaski Hwy, Salem Center, Bear, DE 19701 Phone: 302-834-1550 Fax: 302-834-1549 | |
Frank Austin Jr., Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 Mariners Way, Bear, DE 19701 Phone: 302-832-9167 |